Rhythm Pharmaceuticals, Inc. (RYTM)
105.02
-2.02
(-1.89%)
USD |
NASDAQ |
Jan 02, 16:00
105.02
0.00 (0.00%)
After-Hours: 19:19
Rhythm Pharmaceuticals Research and Development Expense (TTM): 165.86M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.56B |
| Gilead Sciences, Inc. | 5.734B |
| Johnson & Johnson | 15.77B |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Geron Corp. | 81.32M |